Valuation: Cencora, Inc.

Capitalization 5.77TCr 4.98TCr 4.65TCr 4.3TCr 7.94TCr 4,96700Cr 8.9TCr 56TCr 21TCr 2,32500Cr 22TCr 21TCr 8,57300Cr P/E ratio 2025 *
24x
P/E ratio 2026 * 20.8x
Enterprise value 6.14TCr 5.29TCr 4.94TCr 4.57TCr 8.43TCr 5,27900Cr 9.46TCr 60TCr 23TCr 2,47200Cr 23TCr 23TCr 9,11100Cr EV / Sales 2025 *
0.19x
EV / Sales 2026 * 0.17x
Free-Float
35.16%
Yield 2025 *
0.74%
Yield 2026 * 0.76%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.03%
1 week-0.80%
Current month-1.63%
1 month+0.60%
3 months+2.86%
6 months+21.86%
Current year+31.28%
More quotes
1 week 291.19
Extreme 291.19
298.44
1 month 287.43
Extreme 287.43
303.18
Current year 223.92
Extreme 223.92
309.35
1 year 218.65
Extreme 218.65
309.35
3 years 135.14
Extreme 135.14
309.35
5 years 92
Extreme 92
309.35
10 years 68.38
Extreme 68.38
309.35
More quotes
Manager TitleAgeSince
Chief Executive Officer 58 01/10/2024
Director of Finance/CFO 62 09/11/2018
Chief Tech/Sci/R&D Officer 49 04/11/2024
Director TitleAgeSince
Chairman 63 03/03/2016
Director/Board Member 74 16/05/2013
Director/Board Member 58 01/10/2024
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.03%-0.80%+31.00%+110.08% 5.77TCr
-8.12%-9.03%+16.10%+13.56% 23TCr
-0.46%-0.05%+9.96%+1.66% 12TCr
+0.89%+1.24%-23.22%-23.31% 5.11TCr
+0.85%+6.42%-9.93%+43.09% 4.23TCr
+0.29%-1.12%-26.27%+9.75% 3.3TCr
+0.41%-1.35%-11.31%+13.03% 2.44TCr
-1.07%-2.45%-1.60%+8.24% 2.24TCr
-0.75%-6.22%+11.28%-41.08% 2.21TCr
-1.27%-4.44%+43.79%+26.11% 2.03TCr
Average -1.03%-0.50%+3.98%+16.11% 6.17TCr
Weighted average by Cap. -3.12%-0.36%+8.06%+17.38%
See all sector performances

Financials

2025 *2026 *
Net sales 32TCr 28TCr 26TCr 24TCr 44TCr 27,67000Cr 50TCr 3,13700Cr 1,18100Cr 12,95600Cr 1,20600Cr 1,18100Cr 47,76200Cr 34TCr 30TCr 28TCr 26TCr 47TCr 29,57600Cr 53TCr 3,35300Cr 1,26300Cr 13,84900Cr 1,28900Cr 1,26300Cr 51,05300Cr
Net income 232.44Cr 200.57Cr 187.05Cr 173.31Cr 319.54Cr 20TCr 358.53Cr 2.27TCr 853.67Cr 9.36TCr 871.85Cr 853.81Cr 35TCr 266.54Cr 230Cr 214.5Cr 198.74Cr 366.43Cr 23TCr 411.14Cr 2.6TCr 978.93Cr 11TCr 999.78Cr 979.09Cr 40TCr
Net Debt 362.68Cr 312.96Cr 291.86Cr 270.42Cr 498.6Cr 31TCr 559.43Cr 3.54TCr 1.33TCr 15TCr 1.36TCr 1.33TCr 54TCr -34Cr -29Cr -28Cr -25Cr -47Cr -2.94TCr -53Cr -333.4Cr -125.53Cr -1.38TCr -128.2Cr -125.55Cr -5.08TCr
More financial data * Estimated data
Logo Cencora, Inc.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Employees
44,000
More about the company
Date Price Change Volume
18/25/18 294.91 $ -0.98% 4,57,605
16/25/16 297.83 $ +1.08% 13,23,727
15/25/15 294.65 $ -0.81% 9,16,423
14/25/14 297.06 $ +0.63% 9,18,686
11/25/11 295.21 $ -0.71% 9,70,825

Delayed Quote Nyse, July 18, 2025 at 12:50 am IST

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
297.83USD
Average target price
324.30USD
Spread / Average Target
+8.89%
Consensus

Quarterly revenue - Rate of surprise